Granada, Spain

Juan Carlos Morales Sánchez

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Juan Carlos Morales Sánchez

Introduction

Juan Carlos Morales Sánchez is a notable inventor based in Granada, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating various diseases. With a total of 3 patents, his work focuses on innovative therapeutic solutions.

Latest Patents

One of his latest patents is titled "Silylated derivatives of resveratrol and the use thereof in neurodegenerative, neurological or inflammatory diseases." This invention relates to a group of compounds derived from resveratrol, which include at least one silyl group that can be substituted by different groups. The therapeutic use of these compounds targets inflammatory, neurological, and neurodegenerative diseases. Another significant patent is "Acylated compounds for the treatment of ocular pathologies." This invention focuses on the therapeutic use of acylated piceid derivative compounds specifically for ocular conditions, including retinitis pigmentosa and age-related macular degeneration.

Career Highlights

Throughout his career, Juan Carlos has worked with esteemed organizations such as the Consejo Superior de Investigaciones Científicas and Puleva Biotech, S.A. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Juan Carlos has collaborated with notable professionals in his field, including Pablo Peñalver Puente and Arjan Geelings. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Juan Carlos Morales Sánchez is a distinguished inventor whose work in medicinal chemistry has led to innovative solutions for treating various diseases. His patents reflect a commitment to advancing healthcare through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…